Shares of Myovant were up nearly 30% on Monday on record trading volume after Wall Street learned that its parent company Sumitovant Biopharma unveiled an agreement with Pfizer Inc. to jointly develop a treatment for prostate cancer and women’s health. The deal is worth up to $4.2 billion in upfront and potential milestone payments. Both … Continue reading “Myovant Explodes on Pfizer Prostate Cancer Drug Collaboration News”
Biotech & Pharma
Biotech & Pharma
Pfizer Nears a Deal with U.S. Government for an Additional 100 Million Coronavirus Vaccine Doses
According to CNBC's Meg Tirrell, Pharmaceutical giant and the U.S. government are close to a…
December 23, 2020
Biotech & Pharma
FDA Gives Green Light to Abbott’s Rapid $25 Covid Test for At Home Use
As the nation anticipates the FDA giving emergency clearance this week to Moderna's coronavirus vaccine,…
December 17, 2020
Biotech & Pharma
FDA Reviews Moderna’s COVID Vaccine for Emergency Clearance
In a report on Tuesday, the Food and Drug Administration had confirmed that in Moderna's…
December 17, 2020
Biotech & Pharma
Oncocyte Shares Explode on Licensing Deal with China’s Burning Rock Biotech
Shares of Oncocyte were soaring higher this week as Wall Street learned that the company…
December 17, 2020
Biotech & Pharma
Pfizer’s Covid Vaccine is Now Being Shipped with UPS and Fedex
Coronavirus has ravaged most of the year but what a holiday gift the world has…
December 14, 2020
Biotech & Pharma
Immutep Explodes 190% on Positive Breast Cancer Treatment Trial Results
Shares of Australian biotech Immutep were soaring 190% on Thursday after Wall Street learned that…
December 10, 2020
Biotech & Pharma
Pfizer’s Covid-19 Vaccine Could Be Authorized by the FDA this Week
As deaths from coronavirus continue to mount in the U.S., many are paying close attention…
December 7, 2020
Biotech & Pharma
Merck & Co. Sells its Stake in Moderna as it Coronavirus Vaccine Gets FDA Review
Multi-national pharmaceutical company Merck & Co. has sold its direct equity investment in biotech company…
December 4, 2020
Biotech & Pharma
AstraZeneca Says Another COVID-19 Vaccine Study is Likely
Pharmaceutical company AstraZeneca may be conducting another study of its COVID-19 vaccine after accidental lower…
December 1, 2020
Biotech & Pharma
Moderna Files for Emergency Use Authorization for COVID-19 Vaccine
Moderna announced this week the details of its Phase 3 results and has noted that…
December 1, 2020
Biotech & Pharma
Merck to Acquire Oncolmmune to Gain Promising Corona Drug
Pharma giant Merck announced this week that it plans to acquire Oncolmmune, a private held…
November 23, 2020
Biotech & Pharma
Regeneron CEO Says Company Will Provide 300,000 Doses of Covid Treatment for US by January
Regeneron Chief Executive Dr. Leonard Schleifer has said to CNBC that the company will be…
November 23, 2020
Biotech & Pharma
Pfizer Now Says Coronavirus Vaccine is 95% Effective and Has Passed Safety Checks
The race is on for a coronavirus vaccine to hit the market as cases continue…
November 19, 2020